Evolution of ultrasound in giant cell arteritis

Colm Kirby; Rachael Flood; Ronan Mullan; Grainne Murphy; David Kane

doi:10.3389/fmed.2022.981659

Evolution of ultrasound in giant cell arteritis

Front Med (Lausanne). 2022 Oct 3:9:981659. doi: 10.3389/fmed.2022.981659. eCollection 2022.

Authors

Colm Kirby^{1

2}, Rachael Flood¹, Ronan Mullan¹, Grainne Murphy², David Kane¹

Affiliations

¹ Department of Rheumatology, Tallaght University Hospital and Trinity College Dublin, Dublin, Ireland.
² Department of Rheumatology, Cork University Hospital and University College Cork, Cork, Ireland.

Abstract

Ultrasound (US) is being increasingly used to diagnose Giant Cell Arteritis (GCA). The traditional diagnostic Gold Standard has been temporal artery biopsy (TAB), but this is expensive, invasive, has a false-negative rate as high as 60% and has little impact on clinical decision-making. A non-compressible halo with a thickened intima-media complex (IMC) is the sonographic hallmark of GCA. The superficial temporal arteries (STA) and axillary arteries (AA) are the most consistently inflamed arteries sonographically and imaging protocols for evaluating suspected GCA should include at least these two arterial territories. Studies evaluating temporal artery ultrasound (TAUS) have varied considerably in size and methodology with results showing wide discrepancies in sensitivity (9-100%), specificity (66-100%), positive predictive value (36-100%) and negative predictive value (33-100%). Bilateral halos increase sensitivity as does the incorporation of pre-test probability, while prior corticosteroid use decreases sensitivity. Quantifying sonographic vasculitis using Halo Counts and Halo Scores can predict disease extent/severity, risk of specific complications and likelihood of treatment response. Regression of the Halo sign has been observed from as little as 2 days to as late as 7 months after initiation of immunosuppressive treatment and occurs at different rates in STAs than AAs. US is more sensitive than TAB and has comparable sensitivity to MRI and PET/CT. It is time-efficient, cost-effective and allows for the implementation of fast-track GCA clinics which substantially mitigate the risk of irreversible blindness. Algorithms incorporating combinations of imaging modalities can achieve a 100% sensitivity and specificity for a diagnosis of GCA. US should be a standard first line investigation in routine clinical care of patients with suspected GCA with TAB reserved only for those having had a normal US in the context of a high pre-test probability.

Keywords: biomarkers; giant cell (temporal) arteritis; large vessel vasculitis; temporal artery biopsy; ultrasound.

Publication types

Review